Qube Research & Technologies (QRT)
IMDX

Qube Research & Technologies (QRT)’s Insight Molecular Diagnostics IMDX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IMDX Stock Details IMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$82.8K Sell
25,230
-3,121
-11% -$18.1K ﹤0.01% 3093
2025
Q4 		$213K Buy
+28,351
New +$160K ﹤0.01% 3043
2024
Q3 		– Sell
-1
Closed -$3 – 3873
2024
Q2 		$3 Hold
1
– – ﹤0.01% 3674
2024
Q1 		$3 Hold
1
– – ﹤0.01% 4350
2023
Q4 		$2 Hold
1
– – ﹤0.01% 4244
2023
Q3 		$3 Buy
+1
New +$4 ﹤0.01% 3990
2022
Q4 		– Sell
-2,720
Closed -$40K – 2842
2022
Q3 		$40K Sell
2,720
-207
-7% -$3.58K ﹤0.01% 2183
2022
Q2 		$53K Buy
+2,927
New +$66.6K ﹤0.01% 2110

Other funds holding IMDX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Qube Research & Technologies (QRT)'s IMDX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its Insight Molecular Diagnostics (IMDX) stake by 11% in Q1 2026, selling an estimated $18.1K and leaving 25,230 shares worth $82.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3093.

Qube Research & Technologies (QRT) first reported a position in IMDX in Q2 2022 and has held it in 8 quarters since. The position peaked at $213K in Q4 2025. 41 funds tracked by Wall St. Rank hold IMDX as of Q1 2026.

  • Qube Research & Technologies (QRT) held 25,230 shares of Insight Molecular Diagnostics worth $82.8K as of Q1 2026.
  • Qube Research & Technologies (QRT) sold 3,121 Insight Molecular Diagnostics shares in Q1 2026, an estimated $18.1K.
  • Insight Molecular Diagnostics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #3093 holding.
  • Qube Research & Technologies (QRT) first reported a position in Insight Molecular Diagnostics in Q2 2022 and has held it in 8 quarters since.
  • Qube Research & Technologies (QRT)'s Insight Molecular Diagnostics position peaked at $213K in Q4 2025.
  • 41 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.